Increase in the circulating endocannabinoid 2-arachidonoylglycerol is associated with gabapentin use in septic ICU patients. Endocrine 2017 Oct;58(1):203-204
Date
09/07/2017Pubmed ID
28875451DOI
10.1007/s12020-017-1399-xScopus ID
2-s2.0-85028974393 (requires institutional sign-in at Scopus site)Author List
Raff H, Kramer DJ, Hillard CJAuthors
Cecilia J. Hillard PhD Associate Dean, Center Director, Professor in the Pharmacology and Toxicology department at Medical College of WisconsinHershel Raff PhD Professor in the Academic Affairs department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
APACHEAged
Aged, 80 and over
Amines
Analgesics
Arachidonic Acids
Critical Care
Critical Illness
Cyclohexanecarboxylic Acids
Endocannabinoids
Female
Glycerides
Humans
Intensive Care Units
Male
Middle Aged
Sepsis
gamma-Aminobutyric Acid